News

BioForward is actively engaged with community partners, elected officials, state agencies and industry partners to meet the challenges of combating the coronavirus and demonstrating that Wisconsin can help lead the nation through this healthcare crisis. PPE Focus Eight Madison-area community providers serving people with developmental disabilities and seniors received much-needed PPE as they battle the […]

Read the full press release from Amgen here. Amgen (NASDAQ:AMGN) and Adaptive Biotechnologies (NASDAQ:ADPT) today announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and develop fully human neutralizing antibodies targeting SARS-CoV-2 to potentially prevent or treat COVID-19. The mutually exclusive collaboration brings together Adaptive’s proprietary immune medicine […]

Read the full story from BizTimes here. Milwaukee-based Versiti, Inc. will soon begin collecting plasma from recovered COVID-19 patients to potentially treat those with the virus. As researchers race to develop vaccines and treatments for COVID-19, blood centers across the country are beginning to collect plasma for the investigational therapy, which is expected to be […]

Read the full story from BizTimes here. Wisconsin Gov. Tony Evers announced on Monday a new public-private partnership that is expected to double the state’s current COVID-19 testing capacity. Under the partnership, labs operated by Madison-based Exact Sciences Corp., Marshfield Clinic Health System, Madison-based Promega Corp. and UW Health will join an existing network of […]

Read the full press release here. With promising results on its first rheumatological protein therapies, Dianomi is strategically expanding upon its core technology to deliver next-generation nucleic acid therapies MADISON, Wis., Feb. 11, 2020 /PRNewswire/ — Dianomi Therapeutics Inc. today announced that it has licensed a second suite of intellectual property (IP) from the Wisconsin Alumni Research Foundation […]